About Scale Biosciences
Scale Biosciences is a Healthcare company based in San Diego (United States) founded in 2020 by Frank Steemers, and was acquired by 10X Genomics in August 2025. Scale Biosciences is a company developing single-cell library preparation kits for genomic, epigenomic, and transcriptomic analysis. Its chief executive, as recorded, is Giovanna Prout. Its website scale.bio draws about 11 thousand monthly visits.
Company details
Scale Biosciences was founded in 2020 and is headquartered in San Diego, United States. Operations focus on the biotechnology sector, where single-cell library preparation kits are developed using patented combinatorial indexing technology. These kits support genomic, epigenomic, and transcriptomic analysis to enable detailed biological studies. The company is led by co-founder Frank Steemers and CEO Giovanna Prout.
- Headquarters San Diego, United States
- Founders Frank Steemers
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website scale.bio
- Social LinkedIn X
- Acquired by 10X Genomics (Aug 2025)
- Investors
- Acquired by10X Genomics
(Aug 2025)
Investors in Scale Biosciences
Scale Biosciences has secured backing from 1 investor. Prominent investors backing the company include 10X Genomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Instrument systems for genomic research and sequencing libraries are developed. | 2012 | 10xgenomics.com | Pleasanton, United States |
Investor details for Scale Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Scale Biosciences
14 people are tracked at Scale Biosciences (4 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Frank Steemers | Co-Founder | Leadership |
Giovanna Prout | CEO | Leadership |
Melanie Masuda | Director, Market Development | Leadership |
Keith Jackson | Head Of Product Management | Leadership |
Bryce Alves | Staff Scientist | Team |
Tushar Shah | Senior Sales Specialist | Team |
Nicholas Pervolarakis, PhD | Senior Bioinformatics Scientist | Team |
Phuong Dang | Scientist | Team |
Qiang Li | Sr. Staff Scientist | Team |
Kristin Kelley | Sr. Sales Specialist | Team |
Amy Hamilton | Global Marketing Programs Manager | Team |
Jennifer Michaud | Production Manager | Team |
Katharina Danielski | Senior Field Application Scientist | Team |
Sanika Khare | Application Scientist | Team |
Complete people profiles for Scale Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Scale Biosciences
2 dated milestones of Scale Biosciences across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Scale Biosciences is founded.
- Exit Acquired by 10X Genomics.
Web traffic of Scale Biosciences
The website of Scale Biosciences (scale.bio) receives about 11.3K visits a month.
- Monthly visits11.3K
▲ 19.5% vs previous month
Websites whose visitors overlap most with Scale Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| parsebiosciences.com | 100% | 62.7K | #493,988 | View details | |
| cellecta.com | 84% | 16.5K | #1,583,800 | View details | |
| nature.com | 80% | 33.6M | #1,922 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Scale Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Scale Biosciences
Complete news archive for Scale Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scale Biosciences
Scale Biosciences was founded in 2020.
Scale Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Giovanna Prout is the CEO of Scale Biosciences, as recorded in our data.
Scale Biosciences was founded in 2020 and is headquartered in San Diego, United States. Operations focus on the biotechnology sector, where single-cell library preparation kits are developed using patented combinatorial indexing technology. These kits support genomic, epigenomic, and transcriptomic analysis to enable detailed biological studies. The company is led by co-founder Frank Steemers and CEO Giovanna Prout.
Scale Biosciences has 1 investor. Key investors include 10X Genomics.
Yes. Scale Biosciences was acquired by 10X Genomics in August 2025.

